Shoba Mammen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shoba Mammen has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Asha Mary Abraham
Department of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India
4 shared publications- Asha Mary Abraham
Christian Medical College
3 shared publications - Kakhangchung Panmei
Department of Clinical Virology, Christian Medical College, Vellore, India
2 shared publications A. T. Prabhakar
Department of Neurology, Christian Medical College, Vellore, Tamil Nadu, India
1 shared publication- Abdul Hakeem Syed
Dept. of Clinical Virology, Christian Medical College, Vellore, Tamil Nadu, India
1 shared publication Aiswarya Nair
Department of Medicine, Christian Medical College, Vellore, Tamil Nadu, India
1 shared publication
Latest Publications
- 5 August 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 57, 100948
Human papillomavirus infection in non-cervical sites in India
- 5 August 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 57, 100948
Human papillomavirus infection in non-cervical sites in India
- Open Access
- 16 June 2025
- Published by Wolters Kluwer Health in Asian Journal of Transfusion Science
- Vol. 20 (2) , 320-325
Prevalence of West Nile virus among blood donors among South Indian population
BACKGROUND: West Nile virus (WNV) cases are being increasingly reported from various states in India in the last decade and its one mode of transmission is blood transfusion. AIM: It is crucial to study the serological and molecular prevalence of WNV among South Indian blood donors and this data will help guide policy in blood bank. SUBJECTS AND METHODS: Five hundred consenting South Indian blood donors who were at high risk for WNV infection screened by the blood bank criteria and a specific study questionnaire were recruited for the study during the period 2020–2021. Serum samples from these donors were subjected to both WNV immunoglobulin (Ig) M and IgG testing by indirect enzyme-linked immunosorbent assay (ELISA) (Euroimmun, Germany). Further confirmation of positive samples was done by IgM Capture ELISA (InBios International Inc. USA). A random subset (n = 100) of negative samples (both IgG and IgM) were subjected to WNV real-time polymerase chain reaction (PCR). RESULTS: The number of samples that were positive for West Nile-specific IgG and IgM antibodies were 72% and 0.20%, respectively, among South Indian blood donors. Viremia was negative in a subset of 100 samples by real-time PCR targeting the NS5 region. Age seroprevalence of WNV is statistically significant, with a P = 0.02. CONCLUSIONS: High seroprevalence (72%) of WNV IgG suggests the circulation of WNV among the South Indian population and past exposure to the virus. Since no viremia was detected and very low seroprevalence of IgM, implementing nucleic acid testing for screening for WNV currently among blood donors in South India may not be necessary.
- 16 June 2025
- Published by Wolters Kluwer Health in Asian Journal of Transfusion Science
- Vol. 20 (2) , 320-325
Open AccessPrevalence of West Nile virus among blood donors among South Indian population
BACKGROUND: West Nile virus (WNV) cases are being increasingly reported from various states in India in the last decade and its one mode of transmission is blood transfusion. AIM: It is crucial to study the serological and molecular prevalence of WNV among South Indian blood donors and this data will help guide policy in blood bank. SUBJECTS AND METHODS: Five hundred consenting South Indian blood donors who were at high risk for WNV infection screened by the blood bank criteria and a specific study questionnaire were recruited for the study during the period 2020–2021. Serum samples from these donors were subjected to both WNV immunoglobulin (Ig) M and IgG testing by indirect enzyme-linked immunosorbent assay (ELISA) (Euroimmun, Germany). Further confirmation of positive samples was done by IgM Capture ELISA (InBios International Inc. USA). A random subset (n = 100) of negative samples (both IgG and IgM) were subjected to WNV real-time polymerase chain reaction (PCR). RESULTS: The number of samples that were positive for West Nile-specific IgG and IgM antibodies were 72% and 0.20%, respectively, among South Indian blood donors. Viremia was negative in a subset of 100 samples by real-time PCR targeting the NS5 region. Age seroprevalence of WNV is statistically significant, with a P = 0.02. CONCLUSIONS: High seroprevalence (72%) of WNV IgG suggests the circulation of WNV among the South Indian population and past exposure to the virus. Since no viremia was detected and very low seroprevalence of IgM, implementing nucleic acid testing for screening for WNV currently among blood donors in South India may not be necessary.
- 21 April 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 55, 100853
First Human Parechovirus CNS infections from India: a report of two cases
- 21 April 2025
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 55, 100853
First Human Parechovirus CNS infections from India: a report of two cases
- Open Access
- 20 November 2024
- Published by Elsevier in Journal of Virological Methods
- Vol. 332, 115072
Performance evaluation of TaqMan™ Arbovirus Triplex Kit (ZIKV/DENV/CHIKV) for detection and differentiation of dengue and chikungunya viral RNA in serum samples of symptomatic patients
- 20 November 2024
- Published by Elsevier in Journal of Virological Methods
- Vol. 332, 115072
Open AccessPerformance evaluation of TaqMan™ Arbovirus Triplex Kit (ZIKV/DENV/CHIKV) for detection and differentiation of dengue and chikungunya viral RNA in serum samples of symptomatic patients
- 28 October 2024
- Published by Elsevier in Journal of Clinical Virology
- Vol. 175, 105742
Standardization and evaluation of an in-house ELISA for the detection of rabies antibody in a tertiary care centre in South India
- 28 October 2024
- Published by Elsevier in Journal of Clinical Virology
- Vol. 175, 105742
Standardization and evaluation of an in-house ELISA for the detection of rabies antibody in a tertiary care centre in South India
- 17 June 2022
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 40 (3) , 354-358
Comparison of a chemiluminescence immunoassay and an enzyme immunoassay for detection of IgM antibodies against measles, mumps, rubella, cytomegalovirus (CMV), Epstein Barr virus (EBV), and human herpes virus (HHV) -1 and -2 infections
- 17 June 2022
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 40 (3) , 354-358
Comparison of a chemiluminescence immunoassay and an enzyme immunoassay for detection of IgM antibodies against measles, mumps, rubella, cytomegalovirus (CMV), Epstein Barr virus (EBV), and human herpes virus (HHV) -1 and -2 infections
- 28 April 2022
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 40 (3) , 394-398
Changing epidemiology of human enteroviruses (HEV) in a hand, foot and mouth disease outbreak in Vellore, south India
- 28 April 2022
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 40 (3) , 394-398
Changing epidemiology of human enteroviruses (HEV) in a hand, foot and mouth disease outbreak in Vellore, south India
- Open Access
- 16 July 2020
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2020, 1-6
Clinical Features of Four West Nile Virus Cases and Its Molecular Characterization from a South Indian Tertiary Care Hospital
West Nile virus (WNV) is currently a significant reemerging virus of the 21st century. It belongs to the family Flaviviridae and genusFlavivirus. Although it is primarily transmitted by theCulexspp of mosquitoes, other routes of transmission are also well defined. Of eight lineages described, Lineage 1a has been reported from many parts of South India and is known to cause neuroinvasive illness. Many tests and serological techniques have been described to diagnose WNV infection such as complement fixation, neutralization, heamagglutination inhibition, ELISA, and PCR for molecular confirmation. The latter far outweighs the limitations inherent in the other tests. WNV infection is being reported from Vellore for the first time after 1968. This paper aims to describe four cases of WNV infection causing central nervous system manifestations with its molecular characterization. West Nile virus infection was diagnosed with the available molecular techniques such as PCR and sequencing, which emphasizes the need for considering West Nile virus in the differential diagnosis of acute meningoencephalitis and the wider availability of molecular diagnostic tests.
- 16 July 2020
- Published by Wiley in Case Reports in Infectious Diseases
- Vol. 2020, 1-6
Open AccessClinical Features of Four West Nile Virus Cases and Its Molecular Characterization from a South Indian Tertiary Care Hospital
West Nile virus (WNV) is currently a significant reemerging virus of the 21st century. It belongs to the family Flaviviridae and genusFlavivirus. Although it is primarily transmitted by theCulexspp of mosquitoes, other routes of transmission are also well defined. Of eight lineages described, Lineage 1a has been reported from many parts of South India and is known to cause neuroinvasive illness. Many tests and serological techniques have been described to diagnose WNV infection such as complement fixation, neutralization, heamagglutination inhibition, ELISA, and PCR for molecular confirmation. The latter far outweighs the limitations inherent in the other tests. WNV infection is being reported from Vellore for the first time after 1968. This paper aims to describe four cases of WNV infection causing central nervous system manifestations with its molecular characterization. West Nile virus infection was diagnosed with the available molecular techniques such as PCR and sequencing, which emphasizes the need for considering West Nile virus in the differential diagnosis of acute meningoencephalitis and the wider availability of molecular diagnostic tests.